- Report
- February 2024
- 126 Pages
Global
From €4532EUR$4,750USD£3,796GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£999GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2862EUR$3,000USD£2,398GBP
- Report
- February 2024
- 158 Pages
Global
From €5248EUR$5,500USD£4,396GBP
- Report
- October 2024
- 190 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 181 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 197 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 189 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- November 2023
- 180 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- August 2024
- 200 Pages
Global
From €2185EUR$2,290USD£1,830GBP
- Report
- May 2024
- 230 Pages
Global
From €2185EUR$2,290USD£1,830GBP
- Report
- October 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- October 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- August 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more